GlobeNewswire

CallidusCloud Unveils Game-Changing Augmented Intelligence Platform for Sales Performance, Execution and Learning Customers

Dela

Thunderbridge AI³ Combines the Power of Artificial Intelligence, Application Integration, and Human Insight to Provide Contextual Augmented Intelligence Recommendations throughout the Lead to Money suite

DUBLIN, Calif., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Callidus Software Inc. (NASDAQ:CALD), a global leader in cloud-based salesmarketinglearning, and customer experience solutions, unveiled its newest platform, Thunderbridge Augmented Intelligence - or Thunderbridge AI³ - today at CallidusCloud Connections (C3) 2017, its annual user conference. The new solution is comprised of three elements: artificial intelligence, application integration, and human insight.

The Thunderbridge Augmented Intelligence platform is a layer of software that applies machine learning techniques to the sales and learning processes to come up with recommended actions for increasing revenue, profit, and sales effectiveness.

The role of human insight and behavior is key to Thunderbridge AI³.  Recommendations are precisely tailored to individual sales representatives, sales leaders, and sales operations managers and are specific to different stages in a deal. Incentive compensation, training, and learning, are all analyzed with the Thunderbridge AI engine, and are factored into suggested actions that provide real and quick ROI. The solution takes into account all elements of the sales process from the "top of the funnel," to sales enablement and learning, to compensation payouts.

Key to Thunderbridge AI³ is simple implementation without lengthy set up times. Thunderbridge AI³ is integrated seamlessly with CallidusCloud Lead to Money suite already. There is no need for a separate data platform, and no need for data scientists.

"To this day, artificial intelligence applications have been delivered as toolkits with high-profile, expensive implementations that the customer has to manage on its own," said CallidusCloud CEO Leslie Stretch. "With Thunderbridge AI³, that's not the case. We believe AI must augment existing applications and reveal their true capability to automate and optimize business."

CallidusCloud has built the new platform on top of the existing Thunderbridge Analytics product and the new functionality has been years in the making.

The solution was developed with CallidusCloud's deep knowledge of how the B2B sales process works and how integral human behavior and insight is to this process.

"Artificial intelligence should be an extension of data and human insight-not a replacement for humans. Thus recommended actions can be overridden in most cases by users if they do not fit the circumstances," said CallidusCloud EVP and Chief Product Officer, Giles House. "We are enhancing human insight, and making it more valuable," he added.

Applying the Four Laws of Augmented Intelligence

Thunderbridge AI³ was built with four principles or  "laws," that reflect CallidusCloud's approach to Augmented Intelligence

  1. Augmented Intelligence must provide continual improvements in business performance
  2. Augmented Intelligence must enhance individual human performance
  3. Augmented Intelligence must be easy to set up and use
  4. Augmented Intelligence must allow humans to override recommendations unless they conflict with principle #1

Examples of how the principles in this platform can accelerate business include:

  • Sales representatives receive individualized specific recommendations - or mandates, to improve performance and make more money. These include optimal products, bundles, prices and discount levels that increase the chances of closing a deal while considering margin and commissions. Specific learning journeys can be mandated or recommended by Thunderbridge AI³ to help close performance gaps.
  • A sales leader or sales operation manager, can improve its team performance by amending or changing compensation rules around products, or bundles. The changes are recommended by Thunderbridge AI³. Sales leaders can also gain a view into all deals in process and be guided to take actions that move the needle to get to a close by end of quarter.
  • Sales operations managers can gain insight into sales team performance and take action to correct errors such as an excessive compensation payout. These are brought to the attention to Sales Operations by Thunderbridge pro-actively.

About C3
CallidusCloud Connections (C3) 2017 is held September 18-20, 2017, at the Wynn in Las Vegas. It is the largest event in its industry geared toward anyone who's interested in making their sales performance strategy stronger and driving more productive sales reps. Hosted by CallidusCloud, an award-winning sales performance management company, C3 brings together the best solutions, products, and people. C3 attendees walk away from the event with insights that help their organizations save tens of millions in sales commission, gain thousands of hours of productivity, and slash millions from their training costs.

About CallidusCloud
Callidus Software Inc. (NASDAQ:CALD), doing business as CallidusCloud®, is the global leader in cloud-based sales, marketing, learning, and customer experience solutions. CallidusCloud enables organizations to accelerate and maximize their lead to money processes with a complete suite of solutions that identify the right leads, ensure proper territory and quota distribution, enable sales forces, automate configure price quote, speed up contract negotiations, and streamline sales compensation-driving bigger deals, faster. Approximately 5,700 leading organizations, across all industries, rely on the CallidusCloud Lead to Money suite to close more deals and make more money faster.

©2017 Callidus Software Inc. All rights reserved. Callidus, Callidus Software, the Callidus Software logo, CallidusCloud, the CallidusCloud logo, Clicktools, SURVE, syncfrog, TrueComp Manager, ActekSoft, ACom3, iCentera, Webcom, Litmos, the Litmos logo, LeadFormix, Rapid Intake, 6FigureJobs, RevSym, OpenDB and LeadRocket are trademarks, service marks, or registered trademarks of Callidus Software Inc.

Blog: www.calliduscloud.com/salespulse
LinkedIn: www.linkedin.com/company/calliduscloud
Facebook: www.facebook.com/callidussoftware
Twitter: @calliduscloud@calliduscloudIR
Web: www.calliduscloud.com

Press Contact:
Venus Picart
CallidusCloud
(925) 251-2200
vpicart@calliduscloud.com



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Callidus Software via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Stillfront: Simutronics reclaims publishing services10.12.2018 14:11Pressmeddelande

PRESS RELEASE December 10, 2018 Simutronics reclaims the publishing services for SIEGE: Titan Wars globally except China Simutronics Corp, a studio within Stillfront Group AB, has ended a co-publishing agreement regarding the mobile game SIEGE: Titan Wars with New York based publishing partner Tilting Point. According to a new agreement, Tilting Point will continue to provide publishing services and market the game in China but Simutronics will run the publishing services and marketing globally from the Group going forward. Simutronics is a leading developer of online roleplaying and mobile games such as DragonRealms, GemStone IV and Lara Croft Relic Run, the latter with more than 23 million downloads. Tilting Point is a new-generation games partner that provides top development studios with expert resources, services, and operational support to optimize high quality live games for success. "I am very pleased to continue the partnership with Tilting Point for the Chinese market as this

Stillfront: Simutronics återtar förläggartjänster10.12.2018 14:11Pressmeddelande

PRESSMEDDELANDE 2018-12-10 Simutronics återtar förläggartjänster för SIEGE: Titan Wars globalt med undantag för Kina Simutronics, en studio inom Stillfront Group, har avslutat ett medförläggaravtal avseende mobilspelet SIEGE: Titan Wars med den New York-baserade förläggarpartnern Tilting Point. Enligt ett nytt avtal kommer Tilting Point fortsatt att tillhandahålla förläggartjänster och marknadsföring av spelet i Kina men på global nivå kommer Simutronics att ansvara för förläggartjänster och marknadsföring av spelet från gruppen. Simutronics är en ledande utvecklare av rollspel och mobila spel som till exempel DragonRealms, GemStone IV och Lara Croft Relic Run, den sistnämnda med mer än 23 miljoner nedladdningar. Tilting Point är den nya generationens spelbolagspartner som förser ledande utvecklingsstudios med expertis, tjänster och operationell support för att optimera högkvalitativa livespel framgångsrikt. "Jag är mycket nöjd över det fortsatta partnerskapet med Tilting Point för den

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum